# Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy

> **NCT05751915** · — · UNKNOWN · sponsor: **Genetesis Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Coronary Allograft Vasculopathy (CAV)

## Interventions

- **DEVICE:** CardioFlux

## Key facts

- **NCT ID:** NCT05751915
- **Lead sponsor:** Genetesis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-23
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05751915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05751915, "Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05751915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*